US/UK/Canada

Share

Pick a time period -
Tags ( Active)

PanGenomic Health Announces Withdrawal from AQSE

PanGenomic Health Announces Withdrawal from AQSE   Vancouver, British Columbia, Canada, 19 February 2024 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA) announces its intention to withdraw the Company's Class A Common Shares ("Shares") from the Aquis Stock Exchange Growth Market ("AQSE").   Pursuant to the AQSE Access Rulebook, the Company is required to give 20 business days' notice of its intention to withdraw from trading on AQSE. Therefore, trading in the Shares will cease at 4:30 pm, UK time, on 15 March 2024.   The Shares will

PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry

6 December 2023   PanGenomic Health Inc. (“PanGenomic” or the “Company”)   PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry   Vancouver, British Columbia, Canada, 6 December 2023 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics Inc. (“MUJN Diagnostics”), has introduced its point-of-care Vitamin D test for the dental implant industry.   "Vitamin D can play a significant role in the success of a dental implant

PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests

17 November 2023   PanGenomic Health Inc. (“PanGenomic” or the “Company”)   PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests   Vancouver, British Columbia, Canada, 17 November 2023 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics Inc. (“MUJN Diagnostics”), has launched its BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service and completed its first sale of the point-of-care test marketed to health clinics in

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe